Great Minds, Great Outcomes
On July 1, 2014, Actavis (NYSE:ACT) completed the acquisition of Forest Laboratories. The combination of Actavis and Forest creates a new breed of specialty pharmaceutical company, with size and scale, a balanced offering of strong brands and generics, a focus on strategic, lower-risk drug development and a flexible, scalable business model that permits it to adapt quickly to ever-changing industry dynamics and drive sustainable, long-term organic growth.
Join one of the world’s fastest-growing specialty pharmaceutical companies. The combination of Actavis + Forest is creating exciting career opportunities across our now larger and stronger global company. As we continue integrating our recruiting processes and systems, you may view career opportunities at the Actavis and Forest career sites.
Learn more about working at Actavis.